Biotech company enGene to raise $200m in private placement

EnGene Holdings is a Montreal-based biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this